Company News: Merck (MRK) Q4 Earnings Beat Expectations

Market news

3 February 2016

Company News: Merck (MRK) Q4 Earnings Beat Expectations

Merck reported Q4 FY 2015 earnings of $0.93 per share (versus $0.87 in Q4 FY 2014), beating analysts' consensus of $0.91.

The company's quarterly revenues amounted to $10.215 bln (-2.5% y/y), missing consensus estimate of $10.355 bln.

Merck also issued downside guidance for FY 2016, projecting EPS of $3.60-3.75 versus analysts' consensus of $3.72 and revenues of $38.7-40.2 bln versus analysts' consensus of $40.15 bln.

MRK fell to $49.20 (-2.40%) in pre-market trading.

Foreign exchange market. European session: the British pound traded higher against the U.S. dollar after the release of the better-than-expected services PMI data from the U.K.

Orders.

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.